KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Accumulated Depreciation: 2017-2020

Historic Accumulated Depreciation for Aquestive Therapeutics (AQST) over the last 4 years, with Dec 2020 value amounting to $40.9 million.

  • Aquestive Therapeutics' Accumulated Depreciation fell 2.39% to $37.8 million in Q1 2021 from the same period last year, while for Mar 2021 it was $37.8 million, marking a year-over-year decrease of 2.39%. This contributed to the annual value of $40.9 million for FY2020, which is 7.45% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Accumulated Depreciation of $40.9 million as of FY2020, which was up 7.45% from $38.0 million recorded in FY2019.
  • Aquestive Therapeutics' Accumulated Depreciation's 5-year high stood at $40.9 million during FY2020, with a 5-year trough of $32.0 million in FY2017.
  • For the 3-year period, Aquestive Therapeutics' Accumulated Depreciation averaged around $38.0 million, with its median value being $38.0 million (2019).
  • Data for Aquestive Therapeutics' Accumulated Depreciation shows a peak YoY grew of 9.95% (in 2018) over the last 5 years.
  • Aquestive Therapeutics' Accumulated Depreciation (Yearly) stood at $32.0 million in 2017, then grew by 9.95% to $35.2 million in 2018, then grew by 8.11% to $38.0 million in 2019, then rose by 7.45% to $40.9 million in 2020.